Marisol Soengas, Ph.D., head, melanoma group, Spanish National Cancer Research Centre (CNIO), Madrid, Spain

Kai Wucherpfennig, M.D., Ph.D., professor and chair, department of cancer immunology and virology, Dana-Farber Cancer Institute; professor of microbiology and immunobiology, Harvard Medical School; professor of neurology, Brigham and Women’s Hospital and Harvard Medical School

Nicola Allen, Ph.D., assistant professor, molecular neurobiology laboratory, Hearst Foundation Development Chair, Salk Institute

Samantha Butler, Ph.D., associate professor, Brain Research Institute Neurobiology, University of California, Los Angeles

Frederic Charron, Ph.D., associate professor, department of medicine, Montreal Clinical Research Institute (IRCM), McGill University

Claude Desplan, Ph.D., professor, department of biology, director, Center for Developmental Genetics, New York University

Cagla Eroglu, Ph.D., associate professor of cell biology, Duke University

Marc Freeman, Ph.D., director and senior scientist, Vollum Institute

Mary Beth Hatten, Ph.D., Frederick P. Rose Professor, Laboratory of Developmental Neurobiology, The Rockefeller University

Arnold Kriegstein, M.D., Ph.D., professor, University of California, San Francisco

Ophir Shalem, Ph.D., assistant professor, University of Pennsylvania

David Fruman, Ph.D., professor, department of molecular biology and biochemistry, associate director, Cancer Research Institute, University of California, Irvine

Victor Borrell Franco, Ph.D., professor, developmental neurobiology, Institute of Neurosciences, Alicante, Spain

Peter Reddien, Ph.D., professor of biology, associate department head, member and associate director, Whitehead Institute, Massachusetts Institute of Technology; investigator, Howard Hughes Medical Institute